Brief: Haemato Preliminary Q2 EBIT Up At EUR 4.8 Million
11/08/2021 14:49
Aug 11 (Reuters) - HAEMATO AG HAEk.DE :
* INCREASE IN Q2 SALES BY 41% AND EBITDA BY 364% COMPARED TO
THE
SAME QUARTER OF THE PREVIOUS YEAR
* PRELIMINARY GROUP SALES ROSE BY AROUND 41% TO EUR 77.6
MILLION -
AFTER ALREADY 22% GROWTH IN THE FIRST QUARTER OF 2021
* PRELIMINARY HALF-YEAR SALES IN 2021 INCREASED BY 31% TO
151.5
MILLION EUROS
* PRELIMINARY EBIT ROSE TO EUR 4.8 MILLION IN THE SECOND
QUARTER
OF 2021 (PREVIOUS YEAR EUR 0.7 MILLION),
* FOR THE YEAR 2021, CONSOLIDATED SALES OF EUR 280 MILLION
TO EUR
300 MILLION AND AN EBIT OF EUR 9 MILLION TO 11 MILLION ARE
EXPECTED
* NUAL SALES GROWTH OF AROUND EUR 400 MILLION IS TARGETED BY
THE
END OF 2023.
Source text for Eikon: ID:nNDL7ZhV1k
Further company coverage: HAEk.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Haemato AG
See all newsBrief: HAEMATO Raises FY EBIT Guidance to EUR 10-12 Million
Brief: Haemato Says Terminates Cooperation With Korean Manufacturer Huons Biopharma; To Discontinue Project For A Proprietary Botulinum Toxin
Brief: Haemato Q1 EBITDA At EUR 2.3 Mln
Brief: Haemato To Propose Dividend Of EUR 1.10 Per Share
Brief: Haemato Preliminary Consolidated FY EBIT Up At EUR 11.2 Mln